EIQ.AX Echo IQ Limited
Company Analysis
Latest News
🟢 EIQ.AX is trading 30% up today on Pro Medicus funding and US reseller partnership
EIQ.AX is trading 30% up at $1.61 after announcing a strategic funding and commercial deal with Pro Medicus. • Echo IQ has secured a binding framework for up...
🟢 EIQ.AX is trading 27.4% up today on Pro Medicus funding and U.S. partnership deal
EIQ.AX is trading 27.4% up at A$1.58 after announcing a strategic A$20 million funding deal and U.S. commercial partnership with Pro Medicus. • The agreement...
🟢 EIQ.AX is trading 28.6% up today on A$20M Pro Medicus funding and US partnership
EIQ.AX is trading 28.6% up today at A$1.59 after announcing a strategic funding and U.S. commercial partnership with Pro Medicus. • The deal includes up to...
🟢 EIQ.AX is trading 27% up today on A$20M Pro Medicus funding and US partnership
EIQ.AX is trading approximately 27% higher at A$1.57 following the announcement of a strategic funding and U.S. commercial partnership with Pro Medicus. • The...
🟢 EIQ.AX is trading 28% up today on A$20M Pro Medicus funding and US partnership
EIQ.AX is trading 28% up at A$1.59 after announcing a strategic funding agreement and U.S. commercial partnership with Pro Medicus. • The deal provides up to...
🟢 EIQ.AX is trading 28% up today on Pro Medicus funding and US distribution deal
EIQ.AX is trading 28% up at A$1.58 after announcing a strategic funding and U.S. commercial partnership with Pro Medicus. • The agreement provides up to A$20...
🟢 EIQ.AX is trading 31% up today on Pro Medicus funding and US distribution deal
EIQ.AX is trading 31% up at A$1.62 after securing a strategic A$20 million funding package and U.S. distribution partnership with Pro Medicus. • Echo IQ...
🟢 EIQ.AX is trading 30.2% up today after A$20M Pro Medicus funding and US distribution deal
EIQ.AX is trading 30.2% up today at A$1.61 after announcing a major funding and distribution agreement with Pro Medicus to accelerate its U.S. market...
🟢 EIQ.AX is trading 35.1% up today after strategic Pro Medicus investment and U.S. distribution partnership
EIQ.AX is trading 35.1% up at A$1.68 after announcing a strategic investment and U.S. distribution partnership with Pro Medicus. • The deal provides up to...
🟢 EIQ.AX is trading 35.5% up today on Pro Medicus investment and U.S. distribution deal
EIQ.AX is trading 35.5% up at A$1.68 following the announcement of a strategic investment and U.S. distribution partnership with industry leader Pro...
🟢 EIQ.AX is trading 33.9% up today on Pro Medicus investment and US distribution partnership
EIQ.AX is trading 33.9% up at A$1.66 after announcing a strategic investment and U.S. distribution partnership with Pro Medicus. • The binding agreement...
🟢 EIQ.AX is trading 27.4% up today on Pro Medicus investment and U.S. distribution deal
EIQ.AX is trading 27.4% up today at A$1.58 after announcing a strategic investment and U.S. distribution partnership with Pro Medicus. • The framework deal...
🟢 EIQ.AX is trading 24.2% up today on Pro Medicus investment and U.S. distribution deal
EIQ.AX is trading 24.2% up today at A$1.54 after announcing a strategic investment and U.S. distribution partnership with Pro Medicus. • The deal includes an...
🟢 EIQ.AX surges 31.5% today following Pro Medicus investment and distribution deal
EIQ.AX is trading 31.5% up today at A$1.63 after securing a strategic investment and distribution deal with Pro Medicus. • Pro Medicus will make an initial...
🟢 EIQ.AX is trading 34% up today on expectations of imminent FDA clearance for EchoSolv-HF
EIQ.AX is trading 34% up at A$1.67 amid a sharp speculative rally linked to expectations of an imminent U.S. FDA 510(k) decision for its EchoSolv-HF heart...
🟢 EIQ.AX is trading 33% up today on expectations of imminent FDA clearance for EchoSolv-HF
EIQ.AX is trading 33% up at A$1.65 following a sharp speculative rally linked to expectations of an imminent U.S. FDA 510(k) decision on its EchoSolv-HF heart...
🟢 EIQ.AX is trading 44% up today on speculation of FDA clearance for its heart failure AI tool
EIQ.AX is trading 44% up at A$1.78 following a sharp speculative rally tied to expectations of an imminent U.S. FDA decision on its AI-powered heart failure...
Echo IQ Surges 38% on FDA Hopes, but Can a Company With A$91K in Revenue Justify a Near-Billion-Dollar Valuation?
Shares of Echo IQ rocketed 37.9% to A$1.71 on Wednesday, blowing past a week of flat trading near A$1.23, as speculative investors rushed to price in an...
🟢 EIQ.AX is trading 40% up today on FDA decision anticipation and Mayo Clinic collaboration
EIQ.AX is trading 40% up today at $1.74 as investors position ahead of an expected FDA decision on its heart-failure AI tool and respond to growing interest in...
🟢 EIQ.AX is trading 37.9% up today on FDA heart-failure decision anticipation and AI diagnostic momentum
EIQ.AX is trading 37.9% up today at A$1.71 as investors react to upcoming regulatory milestones and renewed interest in the company's AI-driven cardiac...